Role of anti-tumor necrosis factor-α blockers in inducing lupus erythematosus tumidus in "rhupus syndrome"

Journal of Rheumatology

Volumn 38, Issue 6, 2011, Pages 1218-1219

  Chogle, Arun R ^a   Shah, Chirag V ^a   Murthy, Anuradha K ^a  

^a Sir Hurkisondas Nurrotumdas Hospital & Research Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTINUCLEAR ANTIBODY; BISOPROLOL; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN; ETANERCEPT; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; METFORMIN; METHOTREXATE; MUCIN; RO ANTIBODY; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANTIBODY TITER; CASE REPORT; CHEMOLUMINESCENCE; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LETTER; LUPUS ERYTHEMATOSUS TUMIDUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHUPUS SYNDROME; SKIN LUPUS ERYTHEMATOSUS;

ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957849753     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101020     Document Type: Letter

References (10)

1. Soforo E, Baumgartner M, Francis L, Allam F, Phillips PE, Perl A. Induction of systemic lupus erythematosus with tumor necrosis factor blockers [letter]. J Rheumatol 2010;37:204-5.
2. Jacob N, Jacob CO. On anti-tumor necrosis factor-induced systemic lupus erythematosus [editorial]. J Rheumatol 2010;37:3-5.
3. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II associated differences in tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7.
4. Alexiades-Armenakas MR, Baldassano M, Bince B, Werth V, Bystryn JC, Kamino H, et al. Tumid lupus erythematosus: Criteria for classification with immunohistochemical analysis. Arthritis Rheum 2003;49:494-500. (Pubitemid 36988303)
5. Icen M, Nicola PJ, Maradit-Kremers H, Crowson CS, Therneau TM, Matteson EL, et al. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol 2009;36:50-7.
6. Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: A prospective study. Arthritis Res Ther 2005;7:R666-76.
7. Schneider SW, Staender S, Schluter S, Luger TA, Bonsmann G. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. Arch Dermatol 2006;142:115-6. (Pubitemid 43107378)
8. Kuhn A, Bein D, Bonsmann G. The 100th anniversary of lupus erythematosus tumidus. Autoimmun Rev 2009;8:441-8.
9. Amezuca-Guerra LM. Overlap between systemic lupus erythematosus and rheumatoid arthritis. Is it real or just an illusion? [editorial]. J Rheumatol 2009;36:4-6.
10. Clancy RM, Backer CB, Yin X, Chang MW, Cohen SR, Lee LA, et al. Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor?: Implications for pathogenesis. Arthritis Rheum 2004;50:2598-603. (Pubitemid 39062721)